Localization of galectin-3 in normal and diseased pancreatic tissue

International Journal of Pancreatology

Volumn 23, Issue 1, 1998, Pages 1-9

  Schaffert, Courtney ^a   Pour, Parviz M ^a   Chaney, William G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Galectin 3; Pancreatic cancer; Pancreatitis

Indexed keywords

GALECTIN 3;

ANIMAL TISSUE; ARTICLE; CELL ADHESION; CHRONIC PANCREATITIS; GASTROINTESTINAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PANCREAS DISEASE; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR CELL LINE; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, DIFFERENTIATION; CRICETINAE; GALECTIN 3; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MESOCRICETUS; PANCREAS; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031886393     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996; 65: 5-27.
2. Pour PM, Althoff J, Krüger FW, Mohr U. A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine. J Nutl Cancer Inst 1977; 58: 1449-1453.
3. Pour PM, Wilson RB. Experimental pancreas tumors, in Cancer of the Pancreas, Moosa AR, cd. Williams and Wilkins, Baltimore 1980; pp. 37-158.
4. Pour PM, Runge RG, Birt D, Gingell R, Lawson T, Nagel D, Wallcave L, Salmasi SZ. Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to human disease. Cancer 1981; 47: 1573-1587.
5. Pour PM, Tempero MA, Takasaki H, Uchida E, Takiyama Y, Burnett DA, Steplewski Z. Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA19-9 in pancreatic cancer cells in comparison with the patient's blood group type. Cancer Res 1988; 48: 5422-5426.
6. Egami H, Takiyama Y, Chaney WG, Cano M, Fujii H, Tomioka T, Metzgar R, Pour PM. Comparative studies on expression of tumor-associated antigens in human and induced pancreatic cancer in Syrian hamsters. Int J Pancreatol 1990; 3: 296-301.
7. Pour PM, Egami H, Chaney WG, Takiyama Y, Tempero M, Schlom J, Colcher D. Comparative studies on antigen expression in human and experimental pancreatic cancer, in Recent Results in Tumor Diagnosis and Therapy, Klapdor R, ed. W. Zuckschwerdt Verlag Munchen, Bern 1990; pp. 293-296.
8. Schirrmacher V. Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv Cancer Res 1985; 43: 1-73.
9. Bresalier RS. Adhesion molecules and gastrointestinal malignancies. Gastroenterology 1994; 106: 1378-1382.
10. Drickamer K, Taylor ME. Biology of animal lectins. Ann Rev Cell Boil 1993; 9: 237-264.
11. Kasai K, Hirabayashi J. Galectins: a family of animal lectins that decipher glycocodes. J Boichem 1996; 119: 1-8.
12. Barondes SH, Cooper DNW, Gitt MA, Leffler H. Galectins. J Boil Chem 1994; 269: 20,807-20,810.
13. Barondes SH, Castronovo V. Cooper DNW, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, Leffler H, Liu F-T, Lotan R, Mercurio AM, Monsigny M, Pillai S, Poirer F, Raz A, Rigby PWJ. Rini JM, Wang JL. Galectins: a family of animal β-galactoside-binding lectins. Cell 1994; 76: 597,598.
14. Raz A, Meromsky L, Lotan R. Differential expression of endogenous lectins on the surface on nontumorigenic, tumorigenic and metastatic cells. Cancer Res 1986; 46: 3667-3672.
15. Raz A, Meromsky L, Zwibel I, Lotan R. Transformationrelated changes in the expression of endogenous cell lectins. Int J Cancer 1987: 39: 353-360.
16. Raz A, Pazerini G, Carmi P. Identification of the metastasis-associated, galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein. Cancer Res 1989; 49: 3489-3493.
17. Raz A, Zhu D, Hogan V, Shah N, Raz T, Karkash R, Pazerini G, Carmi P. Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis, Int J Cancer 1990; 46: 871-877.
18. Irimura T, Matsushita Y, Sutton RC, Carralero D, Ohannesian DW, Cleary KR, Ota DM, Nicolson GL, Lotan R. Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res 1991; 51: 387-393.
19. Lee EC, Woo H-J, Korzelius CA, Steele GE, Mercurio AM. Carbohydrate-binding protein 35 is the major cell-surface laminin-binding protein in colon carcinoma. Arch Surg 1991; 126: 1496-1502.
20. Ohannesian DW, Lotan D,Thomas P, Jessup JM, Fukuda M, Gabius H-J, Lotan R. Carcinoembryonic antigen and other glycoconjugates act as ligands for galeclin-3 in human colon carcinoma cells. Cancer Res 1995; 55: 2191-2199.
21. Inohara H, Raz A, Identification of human melanoma cellular and secreted ligands for galectin-3. Biochem Biophys Res Comm 1994; 201: 1366-1375.
22. Leffler H, Barondes SH. Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian β-galactosides. J Biol Chem 1986; 261: 10,119-10,126.
23. Feizi T, Solomon JC, Yuen C-T, Jeng KCG, Frigeri LG, Hsu DK, Liu F-T. The adhesive specificity of the soluble human lectin, IgE-binding protein, toward lipid-linked oligosaccharides. Presence of the blood group A, B, B-like, and H monosaccharides confers a binding activity to tetrasaccharide (lacto-N-tetraose and lacto-N-neotetraose) backbones. Biochemistry 1994; 33: 6342-6349.
24. Inohara H, Raz A. Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res 1995; 55: 3267-3271.
25. Probstmeier R, Montag D, Schachner M. Galectin-3, a β-galactoside-binding animal lectin, binds to neural recognition molecules. J Neurochem 1995; 64: 2465-2472.
26. Schoeppner HL, Raz A, Ho SB, Bresalier RS. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer 1995; 75: 2818-2826.
27. Lotz M, Andrews CW, Korzelius CA, Lee EC, Steele GD, Clarke A, Mercurio AM. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 1993; 90: 3466-3470.
28. Castronovo V, Campo K, van den Brule FA, Claysmith AP, Cioce V, Liu F-T, Fernandez PL, Sobel ME. Inversemodulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma. J Natl Cancer Inst 1992; 84: 1161-1169.
29. Ho M-K, Springer TA. Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J Immunol 1982; 128: 1221-1228.
30. Fogh J, Trempe G. New human tumor cell lines, in Human Tumor Cells In Vitro, Fogh J, ed. Plenum, New York and London 1975; pp. 115-159.
31. Lieber M, Mazzetta J, Nelson-Rees W, Kaplan M, Todaro G. Establishment of a continuous tumor-cell line (PANC-1) from a human carcinoma of the exocrine pancreas. Int J Cancer 1975; 15: 741-747.
32. Fogh J, Wright WC, Loveless JD. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst 1977; 58: 209-214.
33. Kim YW, Kern HF, Mullins TD, Koriwchak MJ, Metzgar RS. Characterization of clones of a human pancreatic adenocarcinoma cell line representing different stages of differentiation. Pancreas 1989; 4: 353-362.
34. Takahashi T, Moyer MP, Cano M, Wang QJ, Adrian TE, Mountjoy CP, Sanger W, Sugiura H, Katoh H, Pour PM. Establishment and characterization of a new, spontaneously immortalized, pancreatic ductal cell line from the Syrian golden hamster. Cell Tissue Res 1995; 282: 163-174.
35. Egami H, Takiyama Y, Cano M, Houser WH, Pour PM. Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens. Carcinogenesis 1989; 10: 861-869.
36. Hirota M, Egami H, Corra S, Fujii H, Chaney WG, Rizzino A, Pour PM. Production of scatter factor-like activity by a nitrosamine-induced pancreatic cancer cell line. Carcinogenesis 1993; 14: 259-264.
37. Takiyama Y, Egami H, Pour PM. Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters. Am J Pathol 1990; 136: 707-715.
38. Hsu S-M, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981; 75: 734-738.
39. Hirota M, Mogaki M, Pour PM, Chaney WG. Modification of blood group A antigen expression in a pancreatic cancer cell line (PC-1) by inhibitors of N-glycan processing. J Cell Biochem 1992; 50: 1-8.
40. Smith PK, Krohn RI, Hermanson GT, Mailla AK, Gartner FH, Provenzano MK, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
41. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
42. Takahashi T, Moyer MP, Cano M, Wang QJ. Mountjoy CP, Sanger W, Adrian TE, Sugiura H, Katoh H, Pour PM. Differences in molecular biological, biological and growth characteristics between the immortal and malignant hamster pancreatic cells. Carcinogenesis 1995; 16: 931-939.
43. Massa SM, Cooper DNW, Leffler H, Barondes SH. L-29. an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity. Biochemistry 1993; 32: 260-267.
44. Koths K, Taylor E, Halenbeck R, Casipit C, Wang A. Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J Biol Chem 1993; 268: 14,245-14,249.
45. Levrat JH, Palevody C, Daumas M, RatovoG, Hollande E. Differentiation of the human pancreatic adenocarcinoma cell line (Capan-1) in culture and co-culture with fibroblasts dome formation, Int J Cancer 1988; 42: 615-621.
46. Ochieng J, Fridman R, Nangia-Makker P, Kleiner DE, Liotta LA, Stetler-Stevenson WG, Raz A. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry 1994; 33: 14,109-14,114.
47. Bonfil RD, Farias E, Ruggeri B. Secretion of gelatinases by human pancreatic cancer cell lines: lack of correlation with invasive ability. APPTLA 1995; 45: 185-191.
48. Fowlis D, Colnot C, Ripoche M-A, Poirier F. Galectin-3 is expressed in the notochord, developing bones, and skin of the postimplantation mouse embryo. Dev Dynamics 1995; 203: 241-251.
49. Cameron AA, Dougherty PM, Garrison CJ, Willis WD, Carlton SM. The endogenous lectin RL-29 is transynaptically induced in dorsal horn neurons following peripheral neuropathy in the rat. Brain Res 1993; 620: 64-71.